Veterinary Medicine Information website

CRYOMAREX RISPENS + HVT injekčná suspenzia pre kurčatá

Authorised
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live

Product identification

Medicine name:
CRYOMAREX RISPENS + HVT injekčná suspenzia pre kurčatá
Active substance:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    3.00
    log10 plaque forming unit(s)
    /
    0.20
    millilitre(s)
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    3.00
    log10 plaque forming unit(s)
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Chicken
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/035/99-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 4/08/2022